When indicated for specific conditions, we incorporate LTU-904 Infra-Red Laser Therapy as part of our treatment. This low level laser brings about a photochemical reaction at a cellular level. The laser light penetrates into tissue where it is absorbed by cells and converted into energy that influences the course of metabolic processes.
LTU Infra-Red Laser Therapy is painless and will often bring an immediate analgesic effect at the time of treatment. It dramatically shortens recovery time with rapid reduction of swelling and inflammation.
Laser therapy is recognized and used worldwide for the treatment of numerous injuries. The 904 nanometer wavelength of the LTU models is especially effective in the treatment of:
Lymphedema • Fibrous lesions • Sprained and strained ligaments • Tendon injuries • Muscle soreness • Slow healing skin wounds • Plantar Fasciitis
Benefits of LTU-904 Infra-Red Laser Therapy
- Reduces scar formation
- Reduces pain and inflammation
- Reduces edema or swelling
- Wound healing
- Reduces post injury/surgery recovery time
- Nerve regeneration
- Improves blood circulation
- Increases collagen and reduces cellular substances
- Increases epithelial activity
- Increases capillary blood vessel formation
How frequently should Infra-Red Laser Therapy be used?
The frequency and the duration of the treatment will depend on the type of injury and its severity. Treatments can vary from one short treatment session lasting a few minutes, up to several treatments of longer duration.
Cleared by the FDA for Lymphedema Treatment:
The American Food and Drug Administration has cleared the Riancorp LTU-904 laser therapy units as a tool to be used in the treatment of postmastectomy lymphedema. The LTU-904 is the ONLY laser device cleared by FDA for lymphedema treatment.
Clinical research:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743666/
https://www.ncbi.nlm.nih.gov/pubmed/20704667/
https://www.riancorp.com/static/uploads/files/clinicaltrialsummary-wfxhanqvxxql.pdf
https://www.riancorp.com/static/uploads/files/lllt-for-lymphoedema-overview-wfnqqxptspli.pdf
